218 related articles for article (PubMed ID: 14525573)
1. Sentinel node biopsy in breast cancer: validation study and comparison of blue dye alone with triple modality localization.
Meyer-Rochow GY; Martin RC; Harman CR
ANZ J Surg; 2003 Oct; 73(10):815-8. PubMed ID: 14525573
[TBL] [Abstract][Full Text] [Related]
2. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
3. Sentinel node biopsy versus low axillary sampling in women with clinically node negative operable breast cancer.
Parmar V; Hawaldar R; Nair NS; Shet T; Vanmali V; Desai S; Gupta S; Rangrajan V; Mittra I; Badwe RA
Breast; 2013 Dec; 22(6):1081-6. PubMed ID: 23948301
[TBL] [Abstract][Full Text] [Related]
4. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
5. Retrospective analysis of sentinel node localization in multifocal, multicentric, palpable, or nonpalpable breast cancer.
Kumar R; Jana S; Heiba SI; Dakhel M; Axelrod D; Siegel B; Bernik S; Mills C; Wallack M; Abdel-Dayem HM
J Nucl Med; 2003 Jan; 44(1):7-10. PubMed ID: 12515869
[TBL] [Abstract][Full Text] [Related]
6. Blue dye versus combined blue dye-radioactive tracer technique in detection of sentinel lymph node in breast cancer.
Radovanovic Z; Golubovic A; Plzak A; Stojiljkovic B; Radovanovic D
Eur J Surg Oncol; 2004 Nov; 30(9):913-7. PubMed ID: 15498633
[TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node as a new marker for therapeutic planning in breast cancer patients.
Gipponi M; Bassetti C; Canavese G; Catturich A; Di Somma C; Vecchio C; Nicolò G; Schenone F; Tomei D; Cafiero F
J Surg Oncol; 2004 Mar; 85(3):102-11. PubMed ID: 14991881
[TBL] [Abstract][Full Text] [Related]
8. The use of periareolar intradermal Tc-99m tin colloid and peritumoral intraparenchymal isosulfan blue dye injections for determination of the sentinel lymph node.
Argon AM; Duygun U; Acar E; Daglioz G; Yenjay L; Zekioglu O; Kapkac M
Clin Nucl Med; 2006 Dec; 31(12):795-800. PubMed ID: 17117076
[TBL] [Abstract][Full Text] [Related]
9. Sentinel lymph node biopsy for breast cancer: impact of the number of sentinel nodes removed on the false-negative rate.
Wong SL; Edwards MJ; Chao C; Tuttle TM; Noyes RD; Carlson DJ; Cerrito PB; McMasters KM
J Am Coll Surg; 2001 Jun; 192(6):684-9; discussion 689-91. PubMed ID: 11400961
[TBL] [Abstract][Full Text] [Related]
10. [Exclusive use of blue dye to detect sentinel lymph nodes in breast cancer].
Bühler H S; Rojas P H; Cayazzo M D; Cunill C E; Vesperinas A G; Hamilton S J
Rev Med Chil; 2008 Aug; 136(8):1015-20. PubMed ID: 18949185
[TBL] [Abstract][Full Text] [Related]
11. Pilot study comparing the accuracy of lymphoscintigraphy sentinel lymph node localisation with axillary node dissection in women with operable breast cancer.
Allen B; Campbell I; Desai S; Dray M; Scarlet J
N Z Med J; 2001 May; 114(1132):233-6. PubMed ID: 11453361
[TBL] [Abstract][Full Text] [Related]
12. Sentinel node biopsy for breast cancer: using local results for estimation of risk to the patient.
Wilkinson DS; Wetzig NR; Bennett IC
ANZ J Surg; 2003 Oct; 73(10):811-4. PubMed ID: 14525572
[TBL] [Abstract][Full Text] [Related]
13. Intradermal isotope injection: a highly accurate method of lymphatic mapping in breast carcinoma.
Boolbol SK; Fey JV; Borgen PI; Heerdt AS; Montgomery LL; Paglia M; Petrek JA; Cody HS; Van Zee KJ
Ann Surg Oncol; 2001; 8(1):20-4. PubMed ID: 11206219
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting sentinel lymph node detection failure in breast cancer patients using intradermal injection of the tracer.
Abdollahi A; Jangjoo A; Dabbagh Kakhki VR; Rasoul Zakavi S; Memar B; Naser Forghani M; Mehrabibahar M; Sadeghi R
Rev Esp Med Nucl; 2010; 29(2):73-7. PubMed ID: 19931946
[TBL] [Abstract][Full Text] [Related]
15. The role of sentinel lymph node biopsy with blue dye alone in breast cancer patients with excisional biopsy.
Asoglu O; Ozmen V; Karanlik H; Kecer M; Muzlumznoglu M; Igci A; Parlak M
Acta Chir Belg; 2005; 105(3):291-6. PubMed ID: 16018523
[TBL] [Abstract][Full Text] [Related]
16. Comparison between one day and two days protocols for sentinel node mapping of breast cancer patients.
Ali J; Alireza R; Mostafa M; Naser FM; Bahram M; Ramin S
Hell J Nucl Med; 2011; 14(3):313-5. PubMed ID: 22087458
[TBL] [Abstract][Full Text] [Related]
17. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
18. Localization of the sentinel lymph node in breast cancer by combined lymphoscintigraphy, blue dye and intraoperative gamma probe.
Villa G; Gipponi M; Buffoni F; Vecchio C; Bianchi P; Agnese G; Di Somma C; Catturich A; Rosato F; Tomei D; Nicolò G; Badellino F; Mariani G; Canavese G
Tumori; 2000; 86(4):297-9. PubMed ID: 11016707
[TBL] [Abstract][Full Text] [Related]
19. Sentinel lymph node biopsy in breast cancer: initial experience at Memorial Sloan-Kettering Cancer Center.
O'Hea BJ; Hill AD; El-Shirbiny AM; Yeh SD; Rosen PP; Coit DG; Borgen PI; Cody HS
J Am Coll Surg; 1998 Apr; 186(4):423-7. PubMed ID: 9544956
[TBL] [Abstract][Full Text] [Related]
20. Preoperative lymphoscintigraphy and internal mammary sentinel lymph node biopsy do not enhance the accuracy of lymphatic mapping for breast cancer.
Lawson LL; Sandler M; Martin W; Beauchamp RD; Kelley MC
Am Surg; 2004 Dec; 70(12):1050-5; discussion 1055-6. PubMed ID: 15663043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
